RU2014136560A - Method of neutron-photon therapy for patients with breast cancer - Google Patents

Method of neutron-photon therapy for patients with breast cancer Download PDF

Info

Publication number
RU2014136560A
RU2014136560A RU2014136560A RU2014136560A RU2014136560A RU 2014136560 A RU2014136560 A RU 2014136560A RU 2014136560 A RU2014136560 A RU 2014136560A RU 2014136560 A RU2014136560 A RU 2014136560A RU 2014136560 A RU2014136560 A RU 2014136560A
Authority
RU
Russia
Prior art keywords
neutron
sod
bolus
daily
patients
Prior art date
Application number
RU2014136560A
Other languages
Russian (ru)
Other versions
RU2582214C2 (en
Inventor
Юрий Станиславович Мардынский
Игорь Александрович Гулидов
Алексей Сергеевич Сысоев
Степан Евгеньевич Ульяненко
Гамзат Гашимович Аминов
Владимир Иванович Потетня
Сергей Николаевич Корякин
Юрий Александрович Рагулин
Николай Григорьевич Горбушин
Original Assignee
Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский радиологический центр" Министерства здравоохранения Российской Федерации (ФГБУ "НМИРЦ" Минздрава России)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский радиологический центр" Министерства здравоохранения Российской Федерации (ФГБУ "НМИРЦ" Минздрава России) filed Critical Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский радиологический центр" Министерства здравоохранения Российской Федерации (ФГБУ "НМИРЦ" Минздрава России)
Priority to RU2014136560/14A priority Critical patent/RU2582214C2/en
Publication of RU2014136560A publication Critical patent/RU2014136560A/en
Application granted granted Critical
Publication of RU2582214C2 publication Critical patent/RU2582214C2/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/10X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/103Treatment planning systems
    • A61N5/1031Treatment planning systems using a specific method of dose optimization

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Radiation-Therapy Devices (AREA)

Abstract

1. Способ нейтронно-фотонной терапии больных раком молочной железы, включающий сочетанную нейтронно-фотонную терапию, отличающийся тем, что вначале размещают болюс на облучаемую молочную железу и изменяют конфигурацию органа, обеспечивающую формирование оптимального распределения дозы облучения в опухоли, при этом облучение нейтронами проводят в режиме от 0,2 до 0,4 Гр, ежедневно до СОД 2,0 Гр или по 1,0 Гр в течение 3 сеансов до СОД 3,0 Гр, а затем проводят гамма-облучение ежедневно от 1,0 до 2,0 Гр до СОД 45-50 Гр.2. Способ по п. 1, отличающийся тем, что болюс изготавливают из тканеэквивалентного материала в виде прозрачных пластин с возможностью изменения и фиксации расстояния между ними.3. Способ по п. 1, отличающийся тем, что при планировании лечения оптимальный вклад нейтронной компоненты с учетом ОБЭ в суммарном курсе сочетанной терапии выбирают от 17 до 30%.1. The method of neutron-photon therapy for patients with breast cancer, including combined neutron-photon therapy, characterized in that the bolus is first placed on the irradiated mammary gland and the organ configuration is changed, which ensures the formation of an optimal radiation dose distribution in the tumor, while neutron irradiation is carried out in mode from 0.2 to 0.4 Gy, daily to SOD 2.0 Gy or 1.0 Gy for 3 sessions to SOD 3.0 Gy, and then gamma irradiation daily from 1.0 to 2.0 Gy to SOD 45-50 Gy. 2. A method according to claim 1, characterized in that the bolus is made of tissue-equivalent material in the form of transparent plates with the possibility of changing and fixing the distance between them. The method according to claim 1, characterized in that when planning treatment, the optimal contribution of the neutron component, taking into account RBE in the total course of combination therapy, is selected from 17 to 30%.

Claims (3)

1. Способ нейтронно-фотонной терапии больных раком молочной железы, включающий сочетанную нейтронно-фотонную терапию, отличающийся тем, что вначале размещают болюс на облучаемую молочную железу и изменяют конфигурацию органа, обеспечивающую формирование оптимального распределения дозы облучения в опухоли, при этом облучение нейтронами проводят в режиме от 0,2 до 0,4 Гр, ежедневно до СОД 2,0 Гр или по 1,0 Гр в течение 3 сеансов до СОД 3,0 Гр, а затем проводят гамма-облучение ежедневно от 1,0 до 2,0 Гр до СОД 45-50 Гр.1. The method of neutron-photon therapy for patients with breast cancer, including combined neutron-photon therapy, characterized in that the bolus is first placed on the irradiated mammary gland and the organ configuration is changed, which ensures the formation of an optimal radiation dose distribution in the tumor, while neutron irradiation is carried out in mode from 0.2 to 0.4 Gy, daily to SOD 2.0 Gy or 1.0 Gy for 3 sessions to SOD 3.0 Gy, and then gamma irradiation daily from 1.0 to 2.0 Gy to SOD 45-50 Gy. 2. Способ по п. 1, отличающийся тем, что болюс изготавливают из тканеэквивалентного материала в виде прозрачных пластин с возможностью изменения и фиксации расстояния между ними.2. The method according to p. 1, characterized in that the bolus is made of tissue-equivalent material in the form of transparent plates with the ability to change and fix the distance between them. 3. Способ по п. 1, отличающийся тем, что при планировании лечения оптимальный вклад нейтронной компоненты с учетом ОБЭ в суммарном курсе сочетанной терапии выбирают от 17 до 30%. 3. The method according to p. 1, characterized in that when planning treatment, the optimal contribution of the neutron component, taking into account RBE in the total course of combination therapy, is selected from 17 to 30%.
RU2014136560/14A 2014-09-09 2014-09-09 Method for neutron-photon therapy of breast cancer patients RU2582214C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2014136560/14A RU2582214C2 (en) 2014-09-09 2014-09-09 Method for neutron-photon therapy of breast cancer patients

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2014136560/14A RU2582214C2 (en) 2014-09-09 2014-09-09 Method for neutron-photon therapy of breast cancer patients

Publications (2)

Publication Number Publication Date
RU2014136560A true RU2014136560A (en) 2016-03-27
RU2582214C2 RU2582214C2 (en) 2016-04-20

Family

ID=55638593

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2014136560/14A RU2582214C2 (en) 2014-09-09 2014-09-09 Method for neutron-photon therapy of breast cancer patients

Country Status (1)

Country Link
RU (1) RU2582214C2 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2186591C2 (en) * 1997-02-04 2002-08-10 Научно-исследовательский институт онкологии Томского научного центра СО РАМН Method for neutron-photon therapy of locally spread mammary gland cancer
US8036435B2 (en) * 2007-09-28 2011-10-11 Varian Medical Systems, Inc. Cancer detection, diagnosis, staging, treatment planning, delivery, and monitoring using X-ray attenuation coefficient distributions

Also Published As

Publication number Publication date
RU2582214C2 (en) 2016-04-20

Similar Documents

Publication Publication Date Title
BR112016028964A2 (en) pd-1 and pd-11 antagonist treatment methods in combination with radiation therapy
GB2522583A (en) Tumor treatment with free radical lifetimes enhanced by persistant low strength magnetic field
RU2014136560A (en) Method of neutron-photon therapy for patients with breast cancer
RU2015132335A (en) METHOD FOR EDUCATION OF COLOR CENTERS IN DIAMOND
RU2428227C2 (en) Method of combined photon-neutron therapy of malignant tumours
MX2019014842A (en) Methods of treating brain tumors using combination therapy.
UA110653U (en) METHOD OF TREATMENT OF LOCAL RECURRENCE OF Ovarian cancer
Doornaert et al. Non-coplanar volumetric modulated arc therapy for irradiation of paranasal sinus tumors: In response to Al-Mamgani et al., Highly-conformal intensity-modulated radiotherapy reduced toxicity without jeopardizing outcome in patients with paranasal sinus cancer treated by surgery and radiotherapy or (chemo) radiation. Oral Oncol 2012; 48 (9): 905-11
RU2018143005A (en) METHOD FOR FORMING TUMOR CELL CULTURE RESISTANT TO PROTONS
RU2007129245A (en) METHOD FOR TREATING BREAST CANCER
RU2016141094A (en) METHOD FOR PRE-SEED TREATMENT OF SEEDS
UA118120U (en) METHOD OF COMPLEX TREATMENT OF Ovarian Cancer
RU2010153128A (en) METHOD FOR TREATING SEXUAL CANCER AND DEVICE FOR ITS IMPLEMENTATION
Кутырева Radiotherapy in the treatment of cancer
Singh et al. Result and outcome of shorter fractionation schedule for post-operative cancer breast patients.
Asadi et al. Investigation of Reduction of the Uncertainty of Monte Carlo Dose Calculations in Oncor® Clinical Linear Accelerator Simulation Using the DBS Variance Reduction Technique in Monte Carlo Code BEAMnrc
MX2019014934A (en) Methods of treating brain tumors using combination therapy.
RU2016103343A (en) METHOD OF INTRANTI-TISSUAL RADIATION THERAPY OF PROSTATE CANCER BY SOURCE OF HIGH POWER OF THE IR192 DOSE USING MEDICAL COLLAGEN
Mohiuddin Ifosfamide/mesna
Barateau et al. Implementation in clinical use of a new plan verification software for conformational and modulated treatments
UA98208U (en) METHOD OF TREATMENT OF Cervical Cancer Patients
Merrell et al. PO-1039: Comparison of seed migration to the chest after permanent prostate brachytherapy with loose, stranded or mixed seeds
RU2012101070A (en) DEVICE FOR TREATMENT OF SURFACE LOCATED MALIGNANT SKIN AND Mucous Neoplasms
Matysiak et al. Evaluation of the range shifter model in a commercial proton therapy planning system
RU2014132577A (en) METHOD FOR TREATMENT OF CHRONIC ALCOHOLISM

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20160910